| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.051 | 0.5 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.038 | 0.5 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |